Erez Chimovits is Director & 10% Owner at BiomX Inc. (PHGE). They have made 8 open-market trades across 5 companies since 2018, most recently 2026-08-07.
CIK 0001706399
8 open-market purchases totalling $66.9M since 2018, never a sale. Across 7 scored buys the stock is down 22.6% at ninety days, and 16.4 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 38% | 29% |
| Avg Move | -1.6% | -6.7% | -22.6% |
| Alpha | -8.0% | -7.7% | -16.4% |
| Scored | 8 | 8 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BRVE | BUY | 2026-08-07 | 2026-08-11 | $18.00 | $34.9M | +6.8% | +5.9% | — |
| UPB | BUY | 2024-10-15 | 2024-10-17 | $17.00 | $14.0M | +4.8% | -1.0% | -50.0% |
| LOGC | BUY | 2020-10-01 | 2020-10-05 | $6.00 | $8.9M | -13.8% | -11.9% | -15.4% |
| PHGE | BUY | 2019-12-18 | 2019-12-20 | $8.90 | $36K | -2.9% | -9.9% | -34.7% |
| PHGE | BUY | 2019-12-10 | 2019-12-12 | $8.85 | $78K | +8.9% | +2.2% | +9.4% |
| PHGE | BUY | 2019-12-05 | 2019-12-09 | $8.40 | $86K | +15.6% | +10.9% | +15.6% |
| NVUS | BUY | 2019-05-02 | 2019-05-06 | $3.10 | $4.0M | -18.5% | -38.5% | -71.5% |
| LOGC | BUY | 2018-10-23 | 2018-10-25 | $10.00 | $4.9M | -13.8% | -11.9% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.